vs
ICU MEDICAL INC（ICUI）与Vestis Corp（VSTS）财务数据对比。点击上方公司名可切换其他公司
Vestis Corp的季度营收约是ICU MEDICAL INC的1.2倍（$663.4M vs $540.7M），Vestis Corp净利率更高（-1.0% vs -2.9%，领先1.9%），Vestis Corp同比增速更快（-3.0% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $28.3M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -3.0%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Vestis Corp是北美领先的工作制服、安全防护服饰及配套设施服务供应商，服务覆盖医疗、制造、零售、餐饮住宿、公共服务等多个领域，为企业客户提供定制化的制服租赁、清洁与日常维护解决方案。
ICUI vs VSTS — 直观对比
营收规模更大
VSTS
是对方的1.2倍
$540.7M
营收增速更快
VSTS
高出11.2%
-14.1%
净利率更高
VSTS
高出1.9%
-2.9%
自由现金流更多
ICUI
多$7.7M
$28.3M
两年增速更快
ICUI
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $663.4M |
| 净利润 | $-15.7M | $-6.4M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 2.5% |
| 净利率 | -2.9% | -1.0% |
| 营收同比 | -14.1% | -3.0% |
| 净利润同比 | 34.0% | -868.1% |
| 每股收益（稀释后） | $-0.63 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIVSTS
| Q1 26 | — | $663.4M | ||
| Q4 25 | $540.7M | $712.0M | ||
| Q3 25 | $537.0M | — | ||
| Q2 25 | $548.9M | $673.8M | ||
| Q1 25 | $604.7M | $665.2M | ||
| Q4 24 | $629.8M | $683.8M | ||
| Q3 24 | $589.1M | $684.3M | ||
| Q2 24 | $596.5M | $698.2M |
净利润ICUIVSTS
| Q1 26 | — | $-6.4M | ||
| Q4 25 | $-15.7M | $-12.5M | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $35.3M | $-676.0K | ||
| Q1 25 | $-15.5M | $-27.8M | ||
| Q4 24 | $-23.8M | $832.0K | ||
| Q3 24 | $-33.0M | $-2.3M | ||
| Q2 24 | $-21.4M | $5.0M |
毛利率ICUIVSTS
| Q1 26 | — | — | ||
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — |
营业利润率ICUIVSTS
| Q1 26 | — | 2.5% | ||
| Q4 25 | 1.0% | 2.5% | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 1.9% | 3.7% | ||
| Q1 25 | 2.1% | -1.3% | ||
| Q4 24 | 6.0% | 4.4% | ||
| Q3 24 | 1.4% | 4.4% | ||
| Q2 24 | 1.3% | 5.4% |
净利率ICUIVSTS
| Q1 26 | — | -1.0% | ||
| Q4 25 | -2.9% | -1.8% | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | 6.4% | -0.1% | ||
| Q1 25 | -2.6% | -4.2% | ||
| Q4 24 | -3.8% | 0.1% | ||
| Q3 24 | -5.6% | -0.3% | ||
| Q2 24 | -3.6% | 0.7% |
每股收益（稀释后）ICUIVSTS
| Q1 26 | — | $-0.05 | ||
| Q4 25 | $-0.63 | $-0.10 | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | $-0.01 | ||
| Q1 25 | $-0.63 | $-0.21 | ||
| Q4 24 | $-0.97 | $0.01 | ||
| Q3 24 | $-1.35 | $-0.02 | ||
| Q2 24 | $-0.88 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $41.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $864.4M |
| 总资产 | $4.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIVSTS
| Q1 26 | — | $41.5M | ||
| Q4 25 | — | $29.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $23.7M | ||
| Q1 25 | — | $28.8M | ||
| Q4 24 | $308.6M | $18.6M | ||
| Q3 24 | $312.5M | $31.0M | ||
| Q2 24 | $302.6M | $29.1M |
总债务ICUIVSTS
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — |
股东权益ICUIVSTS
| Q1 26 | — | $864.4M | ||
| Q4 25 | $2.1B | $865.6M | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | $882.2M | ||
| Q1 25 | $2.0B | $876.3M | ||
| Q4 24 | $2.0B | $899.6M | ||
| Q3 24 | $2.0B | $903.1M | ||
| Q2 24 | $2.0B | $901.2M |
总资产ICUIVSTS
| Q1 26 | — | $2.9B | ||
| Q4 25 | $4.1B | $2.9B | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | $2.9B | ||
| Q1 25 | $4.2B | $2.9B | ||
| Q4 24 | $4.2B | $2.9B | ||
| Q3 24 | $4.3B | $2.9B | ||
| Q2 24 | $4.3B | $3.1B |
负债/权益比ICUIVSTS
| Q1 26 | — | — | ||
| Q4 25 | — | 1.35× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $37.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $28.3M |
| 自由现金流率自由现金流/营收 | 6.6% | 4.3% |
| 资本支出强度资本支出/营收 | 4.6% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $45.0M |
8季度趋势，按日历期对齐
经营现金流ICUIVSTS
| Q1 26 | — | $37.7M | ||
| Q4 25 | $60.6M | $30.9M | ||
| Q3 25 | $56.7M | — | ||
| Q2 25 | $11.2M | $22.9M | ||
| Q1 25 | $51.3M | $6.7M | ||
| Q4 24 | $40.2M | $3.8M | ||
| Q3 24 | $36.1M | $295.6M | ||
| Q2 24 | $82.0M | $48.7M |
自由现金流ICUIVSTS
| Q1 26 | — | $28.3M | ||
| Q4 25 | $36.0M | $15.6M | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | $8.0M | ||
| Q1 25 | $36.7M | $-6.9M | ||
| Q4 24 | $16.1M | $-11.0M | ||
| Q3 24 | $16.2M | $267.5M | ||
| Q2 24 | $62.5M | $27.7M |
自由现金流率ICUIVSTS
| Q1 26 | — | 4.3% | ||
| Q4 25 | 6.6% | 2.2% | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | 1.2% | ||
| Q1 25 | 6.1% | -1.0% | ||
| Q4 24 | 2.6% | -1.6% | ||
| Q3 24 | 2.7% | 39.1% | ||
| Q2 24 | 10.5% | 4.0% |
资本支出强度ICUIVSTS
| Q1 26 | — | 1.4% | ||
| Q4 25 | 4.6% | 2.2% | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | 2.2% | ||
| Q1 25 | 2.4% | 2.0% | ||
| Q4 24 | 3.8% | 2.2% | ||
| Q3 24 | 3.4% | 4.1% | ||
| Q2 24 | 3.3% | 3.0% |
现金转化率ICUIVSTS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 9.66× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
VSTS
| Workplace Supplies | $375.2M | 57% |
| Uniforms | $227.7M | 34% |
| Other | $60.5M | 9% |
